GENEVA, July 27 -- NOVAVAX, INC. filed a patent application (IB2026/050325) for “ANTI-SARS-COV-2 SPIKE (S) IMMUNOASSAY AND METHODS OF USE THEREOF”. With publication no. WO/2026/154387, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: G01N 33/569
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....